Web Results


Jan 1, 2016 ... The third case—this time asserting Ohio claims and having them heard in an Ohio federal court—was called Buchanan v. Wyeth. When the plaintiff died, the case became known as Longs after the representative of the estate. On appeal, the case became Wimbush after the initial representative died and ...


Nov 12, 2009 ... Wyeth, Inc., 2008 WL 5592753, at *3 (N.J. Super. Law Div. Oct. 20, 2008). Amiodarone (Cordarone) case. Innovator manufacturer not liable under statutory product liability or any other theory. Buchanan v. Wyeth Pharmaceuticals, Inc., 2008 WL 7136137, slip op. at 1 (Ala. Cir. Dale Co. October 20, 2008).


Jan 11, 2013 ... sued on fraud, misrepresentation, and/or suppression theories by a plaintiff who claims to have been injured while using a generic-equivalent product. ".... " See Buchanan v. Wyeth Pharm,, Inc., No. CV-. 1. 2007-900065, Order at 1 (Ala. Cir. Ct . Oct. 20,. 2008); Green v. Wyeth Pharm., Inc., No. CV-06-3917.


PLIVA, Inc. v. Mensing: Federal Law Preempts State Law Failure to Warn. Claims Against Generic Drug Manufacturers. To understand the decision in Weeks, it is .... Wyeth, Inc., No. CA 10-0491-KD-C (S.D. Ala. Mar. 15, 2011), report and recommendation adopted (S.D. Ala. Apr. 7, 2011); Buchanan v. Wyeth Pharm., Inc., No.


Jul 25, 2017 ... David R. Buchanan and Peter Samberg, on the brief). Paul W. Schmidt ( Covington & Burling LLP) of the District of Columbia bar, admitted pro hac vice, argued the cause for respondents (in A-. 4760-14) and respondents/cross- appellants (in. A-0164-15) Hoffmann-La Roche Inc. and Roche. Laboratories ...


Buchanan was a white individual who sold a house to Warley, a black individual in Louisville, Kentucky. Louisville had an ordinance that prohibited blacks from living on a block where the majority of residents were white. Since 8 of 10 houses were occupied by whites, Warley was not allowed to live on the block. Buchanan  ...


Aug 15, 2014 ... 1See Buchanan v. Wyeth Pharm., Inc., No. CV–2007–900065, Order at 1 (Ala.Cir. Ct. Oct. 20, 2008); Green v. Wyeth Pharm., Inc., No. CV–06–3917 ER (Ala.Cir.Ct. May 14, 2007) .” Discussion. At the outset, we limit the question posed to manufacturers of prescription drugs and not to any distributors thereof.


Citation. Wyeth v. Levine, 555 U.S. 555, 129 S. Ct. 1187, 173 L. Ed. 2d 51, 2009 U.S. LEXIS 1774, 77 U.S.L.W. 4165, CCH Prod. Liab. Rep. P18,176, 21 Fla. L.


May 11, 2017 ... [1] As discussed in my recent article, different estoppel standards have developed in the PTAB and the district courts after the Federal Circuit's decision in Shaw Industries Group., Inc. v. Automated Creel Systems, Inc.[2]. Federal Circuit's Reasoning in Shaw. In Shaw, the Federal Circuit held that an IPR ...